Baraclude: Clinical Trials

5 trials of Baraclude, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 2
Phase 23Unknown 2, Completed 1

Follow Baraclude: new trials by email Literature Review of Baraclude trials Research Report on Baraclude

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting
Baraclude - Hepatitis B Virus
Phase 1CompletedBristol-Myers Squibb62017-05-162023-11-18
A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB
HPDC-T cells & Entecavir, Entecavir, HPDC-T cells & IFN-a-2a - Chronic Hepatitis B
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University4502015-11-012015-11-26
Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)
Pegalyted interferon, Entecavir - Chronic Hepatitis B
Phase 1 / Phase 2UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh202012-03-012012-05-02
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
DV-601, Entecavir - Hepatitis B, Chronic
Phase 1CompletedDynavax Technologies Corporation142009-09-012019-04-16
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Entecavir - Hepatitis B, Chronic
Phase 1 / Phase 2CompletedBristol-Myers Squibb642007-06-302018-05-02

Conditions studied

Hepatitis B, Chronic (4)  ·  Hepatitis B (2)

Sponsors

Bristol-Myers Squibb (2)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Dynavax Technologies Corporation (1)  ·  Third Affiliated Hospital, Sun Yat-Sen University (1)

Countries

Argentina (1)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Japan (1)  ·  Poland (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Lubiao Chen, MD.&PHD. (1)  ·  Mamun A Mahtab, MSc MD FACG (1)

NIH funding

2009 (1)